Showing results 1 to 50 from more than 300,000 results:

Vemurafenib Cobimetinib: Top KOLs in the world



World Rank Name Topic PersonRank Score help
#1
Matthew * ********** (Reveal full name)
Oncology Biomarker Development, Genentech Inc., 1 DNA Way, 9
Also Ranks for:
Vemurafenib Cobimetinib
3 Trial
Negative Breast
Metastatic Melanoma
acquired resistance
Vemurafenib CobimetinibReveal score
#2
Yibing *** (Reveal full name)
Genentech, Inc., South San Francisco, CA; | Genentech, Inc.,
Also Ranks for:
Vemurafenib Cobimetinib
Braf V600
Advisory Consultancy
Kinase Inhibitors
pten status
Vemurafenib CobimetinibReveal score
#3
Grant * ******** (Reveal full name)
Department of Medical Oncology, Peter MacCallum Cancer Centr
Also Ranks for:
Metastatic Melanoma
Braf Inhibitors
Vemurafenib Cobimetinib
Rna Polymerase
cell cycle
Vemurafenib CobimetinibReveal score
#4
James * * ****** (Reveal full name)
Royal Marsden NHS Foundation Trust, London, UK | The Royal M
Also Ranks for:
Renal Cell
Advisory Consultancy
Immune Checkpoint Inhibitors
Nivolumab Ipilimumab
advanced melanoma
Vemurafenib CobimetinibReveal score
#5
Nicholas * ****** (Reveal full name)
PDO, Genentech, Inc., South San Francisco, California, USA |
Also Ranks for:
Induction Chemotherapy
Vemurafenib Cobimetinib
Monoclonal Antibodies
Concomitant Chemoradiotherapy
lung cancer
Vemurafenib CobimetinibReveal score
#6
Georgina * **** (Reveal full name)
Department of Medical Oncology, Royal North Shore Hospital,
Also Ranks for:
Metastatic Melanoma
Advisory Consultancy
Brain Metastases
Braf V600
immune checkpoint inhibitors
Vemurafenib CobimetinibReveal score
#7
Antoni ***** (Reveal full name)
Division of Hematology and Oncology, UCLA David Geffen Schoo
Also Ranks for:
Dendritic Cells
Braf V600
Advisory Consultancy
Monoclonal Antibodies
advanced melanoma
Vemurafenib CobimetinibReveal score
#8
Keith * ******** (Reveal full name)
Dana-Farber Cancer Institute/Harvard Medical School and Mass
Also Ranks for:
Metastatic Melanoma
Braf V600
Advisory Consultancy
Solid Tumors
brain metastases
Vemurafenib CobimetinibReveal score
#9
Jessie * *** (Reveal full name)
Genentech, a Member of the Roche Group, South San Francisco,
Also Ranks for:
Serous Retinopathy
Cobrim Study
Burkitt Lymphoma
Solid Tumors
cobimetinib vemurafenib
Vemurafenib CobimetinibReveal score
#10
Lev * ******* (Reveal full name)
Oncodermatology Department, N. N. Blokhin Russian Cancer Res
Also Ranks for:
Advanced Melanoma
Braf V600
Fgfr2 Expression
Bristolmyers Squibb
modern therapy
Vemurafenib CobimetinibReveal score
#11
Paolo ******* ******** (Reveal full name)
Istituto Nazionale Tumori, IRCCS, Fondazione “G. Pascale", N
Also Ranks for:
Metastatic Melanoma
Advisory Consultancy
Braf V600
Ipilimumab Patients
phase iii
Vemurafenib CobimetinibReveal score
#12
Claus ***** (Reveal full name)
Department of Dermatology, Eberhard Karls University of Tübi
Also Ranks for:
Tumor Thickness
Brain Metastases
Skin Cancer
Lymph Node
melanoma patients
Vemurafenib CobimetinibReveal score
#13
Caroline ****** (Reveal full name)
Gustave Roussy, Villejuif, and Paris-Saclay University, Orsa
Also Ranks for:
Advanced Melanoma
Braf V600
Advisory Consultancy
Immune Checkpoint Inhibitors
monoclonal antibodies
Vemurafenib CobimetinibReveal score
#14
Jean ******* **** (Reveal full name)
Service de Dermatologie et Cancérologie Cutanée, Aix-Marseil
Also Ranks for:
Advisory Consultancy
Advanced Melanoma
Grant Funding
Adjuvant Therapy
travel accommodation expenses
Vemurafenib CobimetinibReveal score
#15
Brigitte ***** (Reveal full name)
Service de Dermatologie, Université de Nantes, CHU Nantes, C
Also Ranks for:
Consultancy Funding
Acne Vulgaris
Mycosis Fungoides
Sézary Syndrome
metastatic melanoma
Vemurafenib CobimetinibReveal score
#16
Daniil * ************* (Reveal full name)
Moscow City Oncology Hospital #62 of Moscow Healthcare Depar
Also Ranks for:
Braf V600
Egfr Mutations
3 Trial
Reference Bevacizumab
abcp bcp
Vemurafenib CobimetinibReveal score
#17
Paul * ******* (Reveal full name)
University of Manchester and The Christie NHS Foundation Tru
Also Ranks for:
Lung Cancer
Small Cell
Phase Iii
Immune Checkpoint Inhibitors
advanced melanoma
Vemurafenib CobimetinibReveal score
#18
Dirk *********** (Reveal full name)
University Hospital Essen, Essen, and German Cancer Consorti
Also Ranks for:
Advisory Consultancy
Braf V600
Grant Funding
Cell Lines
melanoma patients
Vemurafenib CobimetinibReveal score
#19
Mandalà ******** (Reveal full name)
Unit of Medical Oncology, University of Perugia, Perugia, It
Also Ranks for:
Advisory Consultancy
Metastatic Melanoma
Venous Thromboembolism
Braf V600
3 trial
Vemurafenib CobimetinibReveal score
#20
Reinhard * ****** (Reveal full name)
Department of Dermatology, University Hospital Zurich, Zuric
Also Ranks for:
Metastatic Melanoma
Cutaneous Lymphomas
Advisory Consultancy
Cell Lymphoma
braf v600
Vemurafenib CobimetinibReveal score
#21
Michele **** (Reveal full name)
Center for Immuno-Oncology, University Hospital of Siena and
Also Ranks for:
Metastatic Melanoma
Advisory Consultancy
Honoraria Institution
Hla Class
grant funding
Vemurafenib CobimetinibReveal score
#22
Antoni ***** (Reveal full name)
Department of Medicine, University of California, Los Angele
Also Ranks for:
Ras Mutations
Dabrafenib Trametinib
Solid Tumors
Braf Inhibitors
national cancer institute
Vemurafenib CobimetinibReveal score
#23
John * * * ****** (Reveal full name)
Netherlands Cancer Institute, Amsterdam, Netherlands; | Anto
Also Ranks for:
Advisory Consultancy
Renal Cell
Grant Funding
Dna Vaccines
advanced melanoma
Vemurafenib CobimetinibReveal score
#24
Piotr ********* (Reveal full name)
Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria S
Also Ranks for:
Metastatic Melanoma
Gastrointestinal Stromal
Retroperitoneal Sarcoma
Phase Iii
adjuvant imatinib
Vemurafenib CobimetinibReveal score
#25
Victoria * ******** (Reveal full name)
Gallipoli Medical Research Foundation, Greenslopes Private H
Also Ranks for:
Advanced Melanoma
Advisory Consultancy
Braf V600
Complete Resection
travel accommodation expenses
Vemurafenib CobimetinibReveal score
#26
Jeffrey **** ****** (Reveal full name)
Northwestern University, Chicago, IL | Vanderbilt University
Also Ranks for:
Metastatic Melanoma
Renal Cell
Solid Tumors
Braf Inhibitors
clinical activity
Vemurafenib CobimetinibReveal score
#27
Axel ********* (Reveal full name)
Department of Dermatology, University Hospital Schleswig-Hol
Also Ranks for:
Cell Carcinoma
Patient Data
Skin Cancer Classification
Phase 2
primary analysis
Vemurafenib CobimetinibReveal score
#28
Caroline ******** (Reveal full name)
Department of Dermatology, University Hospital of Bordeaux,
Also Ranks for:
Metastatic Melanoma
Adjuvant Dabrafenib
Braf V600
Binimetinib Encorafenib
3 trial
Vemurafenib CobimetinibReveal score
#29
Luc ****** (Reveal full name)
Department of Dermatology, Lyons Cancer Research Center, Lyo
Also Ranks for:
Metastatic Melanoma
Digital Dermoscopy
Confocal Microscopy
Skin Neoplasms
cell carcinoma
Vemurafenib CobimetinibReveal score
#30
Richard * ******* (Reveal full name)
Department of Medicine and Health Sciences, Macquarie Univer
Also Ranks for:
Advisory Consultancy
Braf Inhibitors
Mek Inhibition
Cell Lines
metastatic melanoma
Vemurafenib CobimetinibReveal score
#31
Vanna *************** (Reveal full name)
Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRC
Also Ranks for:
Advanced Melanoma
Advisory Consultancy
Honoraria Grant Funding
Dabrafenib Trametinib
3 trial
Vemurafenib CobimetinibReveal score
#32
Luis ** ** **** ****** (Reveal full name)
for the ATTAIN Investigators | Department of Clinical Oncolo
Also Ranks for:
Breast Cancer
Follicular Lymphoma
Metastatic Melanoma
Cobimetinib Vemurafenib
serous retinopathy
Vemurafenib CobimetinibReveal score
#33
Axel ********* (Reveal full name)
Skin Cancer Unit, German Cancer Research Center (DKFZ), Heid
Also Ranks for:
Advisory Consultancy
Adjuvant Treatment
Phase Iii
Grant Funding
metastatic melanoma
Vemurafenib CobimetinibReveal score
#34
Il **** ***** (Reveal full name)
Celltrion, Inc., Incheon, Republic of Korea. | Biometrics, C
Also Ranks for:
Cobimetinib Vemurafenib
Metastatic Melanoma
Ovarian Cancer
Qtc Interval
celltrion scientific study
Vemurafenib CobimetinibReveal score
#35
Omid * ***** (Reveal full name)
Department of Hematology/Oncology, The Angeles Clinic and Re
Also Ranks for:
Advanced Melanoma
Clinical Activity
Solid Tumors
Ipilimumab Patients
glembatumumab vedotin
Vemurafenib CobimetinibReveal score
#36
Adil * **** (Reveal full name)
Division of Hematology/Oncology, Department of Medicine, Uni
Also Ranks for:
Valproic Acid
Pembrolizumab Patients
Liver Metastasis
Solid Tumors
advanced melanoma
Vemurafenib CobimetinibReveal score
#37
Gabriella ******* (Reveal full name)
Department of Oncodermatology, National Institute of Oncolog
Also Ranks for:
Malignant Melanoma
Braf V600
3 Trial
Social Support
lymph node
Vemurafenib CobimetinibReveal score
#38
Thomas ****** (Reveal full name)
Department of Medical Oncology, CH de Pau, Pau, France; | CA
Also Ranks for:
Situ Hybridization
Eccrine Porocarcinoma
Melanoma Patients
Merkel Cell
generalized vitiligo
Vemurafenib CobimetinibReveal score
#39
Alessandro * * ******* (Reveal full name)
University of California San Francisco (UCSF), San Francisco
Also Ranks for:
Melanoma Patients
Sentinel Node
Adjuvant Therapy
Phase Iii
complete resection
Vemurafenib CobimetinibReveal score
#40
David **** (Reveal full name)
Department of Medical Oncology and Hematology, Princess Marg
Also Ranks for:
Advanced Melanoma
Ipilimumab Nivolumab
Cdkn2a Mutations
Differentiated Grades
germ cell
Vemurafenib CobimetinibReveal score
#41
Helen * ***** (Reveal full name)
Department of Medicine, National and Kapodistrian University
Also Ranks for:
Metastatic Melanoma
Advisory Consultancy
Braf V600
Prognostic Significance
breast cancer
Vemurafenib CobimetinibReveal score
#42
Igor * ******* (Reveal full name)
Roswell Park Comprehensive Cancer Center, Buffalo, NY; | Ros
Also Ranks for:
Advanced Melanoma
Talimogene Laherparepvec
Solid Tumors
Amg 479
immune checkpoint inhibitors
Vemurafenib CobimetinibReveal score
#43
Michael * ******** (Reveal full name)
Medical School, University of Western Australia, Crawley, WA
Also Ranks for:
Metastatic Melanoma
Advanced Solid Tumors
Cell Lung
Antitumor Activity
malignant pleural mesothelioma
Vemurafenib CobimetinibReveal score
#44
Ralf ******* (Reveal full name)
Mühlenkreiskliniken, Ruhr University Bochum Campus Minden, M
Also Ranks for:
Metastatic Melanoma
Advisory Consultancy
Histamine Receptors
Cell Carcinoma
adjuvant treatment
Vemurafenib CobimetinibReveal score
#45
Boguslawa *********** (Reveal full name)
Przychodnia Lekarska KOMED, Konin, Poland | Przychodnia Leka
Also Ranks for:
Subcutaneous Trastuzumab
Metastatic Melanoma
Braf V600
Solid Tumors
phase iii
Vemurafenib CobimetinibReveal score
#46
Celeste ***** (Reveal full name)
Université de Paris, AP-HP Department of Dermatology, Hôpita
Also Ranks for:
Mek Inhibition
Solitary Progression
Combined Braf
Local Therapy
acral melanoma
Vemurafenib CobimetinibReveal score
#47
Christian * ***** (Reveal full name)
Department of Medical Oncology and Immunology, Netherlands C
Also Ranks for:
Advisory Consultancy
Stage Iii
Neoadjuvant Immunotherapy
Homeostatic Proliferation
advanced melanoma
Vemurafenib CobimetinibReveal score
#48
Céleste ****** (Reveal full name)
Department of Dermatology and CIC, Université de Paris, AP-H
Also Ranks for:
Kaposi Sarcoma
Braf V600
Merkel Cell
Human Herpesvirus
metastatic melanoma
Vemurafenib CobimetinibReveal score
#49
Steven * ***** (Reveal full name)
Saint John's Cancer Institute, Santa Monica, CA, USA.
Also Ranks for:
V600e Mutation
Cellular Senescence
Tissue Repair
Metastatic Melanoma
ipilimumab gp100
Vemurafenib CobimetinibReveal score
#50
Brigitte ***** (Reveal full name)
Department of Dermatology, University of Nantes Medical Scho
Also Ranks for:
Ipilimumab 10
Adult Acne
Situ Hybridization
Advanced Melanoma
brentuximab vedotin
Vemurafenib CobimetinibReveal score